Sirius Therapeutics

Sirius Therapeutics

Phase 2
San Diego, United StatesFounded 2018siriusrna.com

Sirius, also known as the Dog Star, is the brightest star in the sky after the sun. Sirius originates from the ancient Greek word for “glowing”, “burning” or “scorching”. Sirius reflects our aspiration to become a pioneer in the field of RNAi medicine and our burning passion for providing patients with revolutionary therapies.靖因药业是一家国际创新生物科技公司,聚焦新一代核酸创新疗法,以人类健康福祉为使命,为慢病防治提供全新解决方案。

Founded
2018
Focus
RNA & Gene Therapy

About

Sirius, also known as the Dog Star, is the brightest star in the sky after the sun. Sirius originates from the ancient Greek word for “glowing”, “burning” or “scorching”. Sirius reflects our aspiration to become a pioneer in the field of RNAi medicine and our burning passion for providing patients with revolutionary therapies.靖因药业是一家国际创新生物科技公司,聚焦新一代核酸创新疗法,以人类健康福祉为使命,为慢病防治提供全新解决方案。

Funding History

2

Total raised: $30M

Series A$25MUndisclosedAug 15, 2022
Seed$5MUndisclosedMay 15, 2021

Company Info

TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 2
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile